CLINICAL_TRIALS
trial_result
· 2016-05-17
Clinical Trial Update: Phase II Study of IL-11 (Neumega) in Von Willebrand Disease [Phase 2]
Summary
Phase II study of IL-11 (Neumega) in Von Willebrand Disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pittsburgh | Conditions: Von Willebrand Disease | Phase 2 | Status: COMPLETED